Works by Rossing, Peter

Results: 451
    1
    2
    3

    Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 13, p. 3573, doi. 10.3390/jcm11133573
    By:
    • Tougaard, Ninna H.;
    • Frimodt-Møller, Marie;
    • Salmenkari, Hanne;
    • Stougaard, Elisabeth B.;
    • Zawadzki, Andressa D.;
    • Mattila, Ismo M.;
    • Hansen, Tine W.;
    • Legido-Quigley, Cristina;
    • Hörkkö, Sohvi;
    • Forsblom, Carol;
    • Groop, Per-Henrik;
    • Lehto, Markku;
    • Rossing, Peter
    Publication type:
    Article
    4
    5
    6
    7
    8

    Effect of spironolactone wash‐out on albuminuria after long‐term treatment in individuals with type 2 diabetes and high risk of kidney disease—An observational follow‐up of the PRIORITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 387, doi. 10.1111/dom.16037
    By:
    • Wasehuus, Victor;
    • Rotbain Curovic, Viktor;
    • Tofte, Nete;
    • Lindhardt, Morten;
    • Currie, Gemma;
    • Delles, Christian;
    • Frimodt‐Møller, Marie;
    • Mischak, Harald;
    • von der Leyen, Heiko;
    • Hansen, Tine Willum;
    • Kümler, Thomas;
    • Persson, Frederik;
    • Rossing, Peter;
    • Stefansen, Rikke;
    • Campbell, Maria Athena;
    • Zimmermann, Silke;
    • Rädisch, Brit;
    • Hävemeier, Anika;
    • Busmann, Annette;
    • Wittkop, Ulrike
    Publication type:
    Article
    9

    The associations between functional vitamin K status and all‐cause mortality, cardiovascular disease and end‐stage kidney disease in persons with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 348, doi. 10.1111/dom.16025
    By:
    • Friis Bryde Nielsen, Camilla;
    • Møller Thysen, Sanne;
    • Bach Kampmann, Freja;
    • Hansen, Tine Willum;
    • Jørgensen, Niklas Rye;
    • Tofte, Nete;
    • Abitz Winther, Signe;
    • Theilade, Simone;
    • Rossing, Peter;
    • Frimodt‐Møller, Marie;
    • Linneberg, Allan
    Publication type:
    Article
    10
    11

    Performance of new and panel CKD‐EPI equations in European adults with type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2501, doi. 10.1111/dom.15536
    By:
    • Iversen, Esben;
    • Christensen, Katrine McLain;
    • Walls, Anne Byriel;
    • Eickhoff, Mie Klessen;
    • von Scholten, Bernt Johan;
    • Frimodt‐Møller, Marie;
    • Hansen, Tine Willum;
    • Persson, Frederik;
    • Rossing, Peter;
    • Rotbain Curovic, Viktor;
    • Houlind, Morten Baltzer
    Publication type:
    Article
    12
    13

    Association of carpal tunnel syndrome with incident diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1976, doi. 10.1111/dom.15482
    By:
    • Jacobsen, Jeppe Ravn;
    • Westergaard, Lucas Malta;
    • Fosbøl, Emil L.;
    • Kristensen, Søren L.;
    • Køber, Lars;
    • Persson, Frederik;
    • Rossing, Peter;
    • Rørth, Rasmus
    Publication type:
    Article
    14

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    15

    Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    16
    17

    Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3152, doi. 10.1111/dom.15209
    By:
    • Rotbain Curovic, Viktor;
    • Houlind, Morten B.;
    • Kroonen, Marjolein Y. A. M.;
    • Jongs, Niels;
    • Zobel, Emilie H.;
    • Hansen, Tine W.;
    • Tavenier, Juliette;
    • Eugen‐Olsen, Jesper;
    • Laverman, Gozewijn D.;
    • Kooy, Adriaan;
    • Persson, Frederik;
    • Rossing, Peter;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    18

    Back Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    19

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    20
    21

    Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3064, doi. 10.1111/dom.15180
    By:
    • Laursen, Jens Christian;
    • Rotbain Curovic, Viktor;
    • Kroonen, Marjolein Y. A. M.;
    • Jongs, Niels;
    • Zobel, Emilie H.;
    • Hansen, Tine W.;
    • Frimodt‐Møller, Marie;
    • Laverman, Gozewijn D.;
    • Kooy, Adriaan;
    • Persson, Frederik;
    • Heerspink, Hiddo J. L.;
    • Hansen, Christian Stevns;
    • Rossing, Peter
    Publication type:
    Article
    22
    23
    24
    25

    Cover Image.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    26

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    27

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. C1, doi. 10.1111/dom.14995
    By:
    • Rossing, Peter;
    • Garweg, Justus G.;
    • Anker, Stefan D.;
    • Osonoi, Takeshi;
    • Pitt, Bertram;
    • Rosas, Sylvia E.;
    • Ruilope, Luis Miguel;
    • Zhu, Dalong;
    • Brinker, Meike;
    • Finis, David;
    • Leal, Sergio;
    • Schmelter, Thomas;
    • Bakris, George
    Publication type:
    Article
    28

    Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 844, doi. 10.1111/dom.14933
    By:
    • Brandt‐Jacobsen, Niels H.;
    • Jürgens, Mikkel;
    • Hasbak, Philip;
    • Gæde, Peter;
    • Rossing, Peter;
    • Rasmussen, Jon J.;
    • Andersen, Camillla Fuchs;
    • Forman, Julie L.;
    • Faber, Jens;
    • Inzucchi, Silvio E.;
    • Gustafsson, Finn;
    • Schou, Morten;
    • Kistorp, Caroline
    Publication type:
    Article
    29

    Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 894, doi. 10.1111/dom.14915
    By:
    • Rossing, Peter;
    • Garweg, Justus G.;
    • Anker, Stefan D.;
    • Osonoi, Takeshi;
    • Pitt, Bertram;
    • Rosas, Sylvia E.;
    • Ruilope, Luis Miguel;
    • Zhu, Dalong;
    • Brinker, Meike;
    • Finis, David;
    • Leal, Sergio;
    • Schmelter, Thomas;
    • Bakris, George
    Publication type:
    Article
    30

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
    By:
    • Rossing, Peter;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Fonseca, Vivian;
    • Umpierrez, Guillermo E.;
    • Caramori, Maria Luiza;
    • Joseph, Amer;
    • Lambelet, Marc;
    • Lawatscheck, Robert;
    • Bakris, George L.
    Publication type:
    Article
    31
    32
    33
    34

    Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 827, doi. 10.1111/dom.14641
    By:
    • Chertow, Glenn M.;
    • Vart, Priya;
    • Jongs, Niels;
    • Langkilde, Anna Maria;
    • McMurray, John J. V.;
    • Correa‐Rotter, Ricardo;
    • Rossing, Peter;
    • Sjöström, C. David;
    • Stefansson, Bergur V.;
    • Toto, Robert D.;
    • Wheeler, David C.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    35
    36
    37
    38

    Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1371, doi. 10.1111/dom.14350
    By:
    • Timmons, Joseph G.;
    • Greenlaw, Nicola;
    • Boyle, James G.;
    • Chaturvedi, Nish;
    • Ford, Ian;
    • Brouwers, Martijn C. G. J.;
    • Tillin, Therese;
    • Hramiak, Irene;
    • Hughes, Alun D.;
    • Jenkins, Alicia J.;
    • Klein, Barbara E. K.;
    • Klein, Ron;
    • Ooi, Teik C.;
    • Rossing, Peter;
    • Stehouwer, Coen D. A.;
    • Sattar, Naveed;
    • Colhoun, Helen M.;
    • Petrie, John R.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions ( REMOVAL): An international multicentre trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 509, doi. 10.1111/dom.12840
    By:
    • Petrie, John R.;
    • Chaturvedi, Nish;
    • Ford, Ian;
    • Hramiak, Irene;
    • Hughes, Alun D.;
    • Jenkins, Alicia J.;
    • E. Klein, Barbara;
    • Klein, Ron;
    • Ooi, Teik Chye;
    • Rossing, Peter;
    • Sattar, Naveed;
    • Stehouwer, Coen D. A.;
    • Colhoun, Helen M.;
    • Ford, I;
    • Kean, S;
    • Thomson, E;
    • Gillespie, L;
    • Gibb, J;
    • Greenlaw, N;
    • Hramiak, I
    Publication type:
    Article
    48
    49

    Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.

    Published in:
    European Journal of Preventive Cardiology, 2017, v. 24, n. 14, p. 1517, doi. 10.1177/2047487317717820
    By:
    • Christensen, Regitse H;
    • von Scholten, Bernt J;
    • Hansen, Christian S;
    • Heywood, Sarah E;
    • Rosenmeier, Jaya B;
    • Andersen, Ulrik B;
    • Hovind, Peter;
    • Reinhard, Henrik;
    • Parving, Hans-Henrik;
    • Pedersen, Bente K;
    • Jørgensen, Marit E;
    • Jacobsen, Peter K;
    • Rossing, Peter
    Publication type:
    Article
    50